| 4.5 |
13.5 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 3.1 |
12.2 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 2.7 |
8.2 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 2.6 |
7.8 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 2.5 |
10.0 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 2.5 |
14.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.9 |
7.8 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.9 |
1.9 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 1.9 |
7.7 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.9 |
13.1 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 1.8 |
5.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 1.8 |
3.7 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 1.7 |
5.2 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 1.7 |
5.2 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 1.7 |
8.7 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 1.7 |
5.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 1.7 |
13.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 1.7 |
6.7 |
GO:0010957 |
negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 1.6 |
4.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 1.6 |
6.4 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.6 |
3.2 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.6 |
8.0 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 1.6 |
4.8 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 1.6 |
4.7 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 1.5 |
1.5 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 1.5 |
6.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.5 |
9.1 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.5 |
4.5 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 1.5 |
4.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 1.5 |
4.5 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 1.5 |
4.4 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 1.5 |
7.4 |
GO:0071038 |
nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
| 1.5 |
7.4 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 1.4 |
5.7 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.4 |
7.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 1.4 |
5.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 1.4 |
11.1 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 1.4 |
8.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 1.4 |
10.9 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 1.4 |
2.7 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 1.3 |
10.7 |
GO:0046645 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 1.3 |
1.3 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 1.3 |
8.0 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.3 |
6.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 1.3 |
5.1 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 1.2 |
5.0 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.2 |
2.5 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 1.2 |
3.6 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 1.2 |
5.9 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 1.2 |
3.5 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.2 |
4.7 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 1.2 |
8.1 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.2 |
3.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 1.2 |
3.5 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 1.1 |
3.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 1.1 |
2.3 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 1.1 |
3.4 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.1 |
3.4 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 1.1 |
3.3 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.1 |
22.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 1.1 |
7.7 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 1.1 |
3.3 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 1.1 |
1.1 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 1.1 |
5.4 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 1.1 |
3.3 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 1.1 |
4.3 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 1.1 |
2.2 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 1.1 |
2.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.1 |
3.2 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 1.1 |
7.5 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 1.1 |
9.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.1 |
3.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 1.0 |
30.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 1.0 |
3.1 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 1.0 |
1.0 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 1.0 |
3.1 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 1.0 |
3.1 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 1.0 |
4.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 1.0 |
1.0 |
GO:0043366 |
beta selection(GO:0043366) |
| 1.0 |
5.0 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.0 |
5.9 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 1.0 |
5.9 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 |
3.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 1.0 |
6.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.0 |
2.9 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 1.0 |
4.9 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 1.0 |
6.8 |
GO:2000002 |
negative regulation of DNA damage checkpoint(GO:2000002) |
| 1.0 |
2.9 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 1.0 |
4.9 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 1.0 |
3.9 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.0 |
1.0 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.9 |
4.7 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.9 |
3.8 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.9 |
3.7 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.9 |
2.8 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.9 |
5.5 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.9 |
3.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.9 |
5.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.9 |
2.7 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.9 |
2.7 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.9 |
3.6 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.9 |
2.7 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.9 |
2.6 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.9 |
0.9 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.9 |
24.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.9 |
2.6 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.8 |
7.6 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.8 |
2.5 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.8 |
2.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.8 |
2.5 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.8 |
3.3 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.8 |
21.4 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.8 |
2.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.8 |
5.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.8 |
0.8 |
GO:1900157 |
regulation of bone mineralization involved in bone maturation(GO:1900157) |
| 0.8 |
9.7 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.8 |
3.2 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.8 |
2.4 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.8 |
4.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.8 |
8.8 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.8 |
3.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.8 |
0.8 |
GO:0060021 |
palate development(GO:0060021) |
| 0.8 |
11.0 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.8 |
3.9 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.8 |
6.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.8 |
1.6 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.8 |
7.0 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.8 |
0.8 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.8 |
7.7 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.8 |
2.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.8 |
3.1 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.8 |
0.8 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.8 |
3.8 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.8 |
2.3 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.8 |
3.0 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.8 |
6.0 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.8 |
2.3 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.7 |
2.2 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.7 |
1.5 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.7 |
2.2 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.7 |
20.1 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.7 |
0.7 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.7 |
0.7 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.7 |
15.3 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.7 |
2.2 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.7 |
0.7 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.7 |
7.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.7 |
5.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.7 |
4.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.7 |
3.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.7 |
5.1 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.7 |
1.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.7 |
0.7 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.7 |
2.8 |
GO:0000469 |
cleavage involved in rRNA processing(GO:0000469) |
| 0.7 |
2.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.7 |
2.1 |
GO:0032916 |
positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.7 |
2.8 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.7 |
5.6 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.7 |
2.1 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.7 |
3.5 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 |
9.6 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.7 |
19.1 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.7 |
2.7 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.7 |
2.0 |
GO:0048382 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) mesendoderm development(GO:0048382) |
| 0.7 |
2.7 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.7 |
2.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.7 |
0.7 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.7 |
24.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.7 |
4.7 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.7 |
2.0 |
GO:0010248 |
B cell negative selection(GO:0002352) establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.7 |
9.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.7 |
4.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.7 |
4.0 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.7 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.6 |
1.9 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.6 |
3.2 |
GO:0051307 |
meiotic chromosome separation(GO:0051307) |
| 0.6 |
5.8 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.6 |
3.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.6 |
5.0 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.6 |
0.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
1.9 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.6 |
1.9 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.6 |
13.6 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.6 |
4.3 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.6 |
1.2 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.6 |
1.8 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.6 |
4.3 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.6 |
2.4 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.6 |
20.0 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.6 |
3.6 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.6 |
18.0 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.6 |
1.2 |
GO:2000192 |
negative regulation of fatty acid transport(GO:2000192) |
| 0.6 |
4.2 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.6 |
1.2 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.6 |
1.7 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.6 |
1.7 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 |
2.9 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.6 |
1.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.6 |
1.2 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.6 |
2.3 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.6 |
13.1 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.6 |
1.7 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.6 |
1.1 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.6 |
12.8 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.6 |
2.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.6 |
2.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.6 |
2.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.6 |
1.1 |
GO:0061038 |
uterus morphogenesis(GO:0061038) |
| 0.5 |
7.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.5 |
2.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.5 |
1.1 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 |
1.6 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 |
1.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.5 |
2.7 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.5 |
1.6 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
4.3 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.5 |
1.6 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.5 |
1.6 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.5 |
3.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.5 |
1.6 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
2.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.5 |
3.2 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.5 |
1.0 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.5 |
3.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
2.1 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.5 |
1.6 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.5 |
3.6 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.5 |
4.6 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.5 |
2.6 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.5 |
2.1 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.5 |
1.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.5 |
0.5 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.5 |
4.0 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.5 |
1.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.5 |
5.0 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
3.0 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.5 |
1.5 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.5 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.5 |
1.9 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.5 |
8.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.5 |
1.0 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.5 |
2.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.5 |
2.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.5 |
0.5 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.5 |
3.8 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.5 |
1.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.5 |
1.4 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.5 |
0.5 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.5 |
1.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.5 |
1.4 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.5 |
1.9 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.5 |
6.1 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.5 |
0.9 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.5 |
1.4 |
GO:0002666 |
positive regulation of T cell tolerance induction(GO:0002666) |
| 0.5 |
3.8 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.5 |
0.9 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 |
1.4 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.5 |
3.3 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 |
2.3 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 |
0.5 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.5 |
0.9 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.5 |
0.9 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.5 |
0.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.5 |
1.8 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.5 |
1.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.5 |
4.1 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.5 |
0.9 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.5 |
2.3 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.5 |
1.4 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.5 |
19.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.5 |
2.3 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.5 |
1.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.5 |
4.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.4 |
0.9 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
0.4 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.4 |
1.3 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.4 |
2.6 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.4 |
16.3 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.4 |
1.3 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.4 |
4.4 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.4 |
1.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
7.4 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.4 |
42.6 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.4 |
1.3 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
| 0.4 |
1.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
0.4 |
GO:1901988 |
negative regulation of cell cycle phase transition(GO:1901988) |
| 0.4 |
3.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.4 |
5.1 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.4 |
0.9 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 |
1.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 |
4.7 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.4 |
2.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
1.3 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.4 |
6.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
2.5 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.4 |
2.9 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.4 |
19.1 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.4 |
7.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.4 |
2.1 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.4 |
7.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.4 |
4.5 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.4 |
8.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.4 |
1.2 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 |
0.4 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.4 |
4.9 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.4 |
0.4 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 |
1.2 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.4 |
1.2 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.4 |
1.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
0.4 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.4 |
0.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 |
4.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.4 |
1.6 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.4 |
0.4 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 0.4 |
2.0 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.4 |
1.2 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.4 |
0.8 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.4 |
1.2 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.4 |
1.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.4 |
0.4 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.4 |
7.7 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.4 |
1.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 |
3.0 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.4 |
1.9 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.4 |
0.8 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.4 |
9.4 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.4 |
1.5 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.4 |
4.1 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.4 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.4 |
4.1 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.4 |
1.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.4 |
0.4 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.4 |
1.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
4.0 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
1.8 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.4 |
8.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.4 |
1.8 |
GO:0043525 |
positive regulation of neuron apoptotic process(GO:0043525) |
| 0.4 |
1.1 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.4 |
1.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.4 |
1.4 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.4 |
5.7 |
GO:0051654 |
establishment of mitochondrion localization(GO:0051654) |
| 0.4 |
1.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
3.2 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.4 |
1.4 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.4 |
1.8 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.4 |
3.9 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.4 |
1.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.4 |
1.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
6.0 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.3 |
1.7 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
0.7 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.3 |
1.4 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 |
2.8 |
GO:0035561 |
regulation of chromatin binding(GO:0035561) |
| 0.3 |
2.1 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.3 |
1.0 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.3 |
1.0 |
GO:0046618 |
drug export(GO:0046618) |
| 0.3 |
1.4 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.3 |
1.4 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.3 |
1.0 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.3 |
0.7 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.3 |
1.0 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
1.4 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 |
3.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
9.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.3 |
1.4 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 |
0.7 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.3 |
1.7 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 |
0.7 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
0.3 |
GO:0022613 |
ribonucleoprotein complex biogenesis(GO:0022613) |
| 0.3 |
1.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.3 |
1.3 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 |
110.8 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.3 |
2.6 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.3 |
2.0 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.3 |
0.7 |
GO:0051305 |
meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
| 0.3 |
1.0 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.3 |
1.6 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.3 |
1.3 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
2.3 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.3 |
1.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
1.3 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.3 |
0.3 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) negative regulation of ERAD pathway(GO:1904293) |
| 0.3 |
1.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.3 |
1.0 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 |
2.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
0.3 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.3 |
0.9 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 |
1.6 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.3 |
0.9 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.3 |
0.9 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.3 |
2.2 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.3 |
0.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.3 |
2.2 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.3 |
2.8 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
0.9 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.3 |
1.5 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.3 |
1.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.3 |
1.2 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.3 |
0.6 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 0.3 |
1.2 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.3 |
3.0 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.3 |
0.6 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.3 |
3.3 |
GO:0070202 |
regulation of establishment of protein localization to chromosome(GO:0070202) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.3 |
1.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
2.4 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.3 |
0.6 |
GO:0010455 |
positive regulation of cell fate commitment(GO:0010455) |
| 0.3 |
2.4 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.3 |
1.2 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.3 |
1.5 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.3 |
0.9 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.3 |
0.6 |
GO:1902866 |
regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
| 0.3 |
2.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.3 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.3 |
11.5 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.3 |
4.7 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.3 |
0.9 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.3 |
0.9 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 |
1.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.3 |
0.9 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.3 |
1.2 |
GO:0002839 |
positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
| 0.3 |
0.3 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.3 |
17.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
1.5 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
2.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.3 |
0.9 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.3 |
13.2 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.3 |
2.6 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
0.9 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.3 |
0.3 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
3.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 |
3.1 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.3 |
0.9 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.3 |
2.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 |
4.8 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.3 |
3.9 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) |
| 0.3 |
2.0 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.3 |
1.4 |
GO:0034351 |
negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.3 |
0.3 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 |
2.2 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.3 |
1.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.3 |
0.6 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.3 |
1.1 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.3 |
0.8 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.3 |
1.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.3 |
0.6 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.3 |
3.8 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.3 |
3.8 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.3 |
1.6 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.3 |
1.4 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.3 |
0.8 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.3 |
0.8 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.3 |
1.1 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.3 |
1.4 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.3 |
2.9 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.3 |
7.5 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.3 |
2.9 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.3 |
0.8 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 |
0.3 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.3 |
1.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
0.5 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.3 |
1.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.3 |
1.6 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.3 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.3 |
1.8 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.3 |
1.0 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.3 |
1.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.3 |
3.9 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.3 |
1.5 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.3 |
7.2 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.3 |
0.3 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.3 |
0.5 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.3 |
1.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
1.0 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.3 |
0.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
2.5 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.7 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.2 |
0.5 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
0.5 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.2 |
0.2 |
GO:0070171 |
negative regulation of tooth mineralization(GO:0070171) |
| 0.2 |
3.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
2.4 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.2 |
0.7 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.2 |
0.5 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.2 |
1.7 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
0.7 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.2 |
0.5 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.2 |
1.2 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
4.3 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
0.5 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.2 |
0.9 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.2 |
1.4 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
0.7 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.2 |
0.5 |
GO:2000144 |
positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.2 |
0.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 |
0.5 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
0.7 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
3.0 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.2 |
1.4 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.2 |
5.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.2 |
1.2 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.2 |
1.4 |
GO:0042511 |
positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
| 0.2 |
1.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.2 |
2.7 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.2 |
0.7 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.2 |
1.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.5 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
1.6 |
GO:0036120 |
cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 |
0.7 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.2 |
0.7 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
1.6 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.5 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.2 |
0.4 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.2 |
1.3 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.2 |
0.2 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
1.5 |
GO:0000070 |
mitotic sister chromatid segregation(GO:0000070) |
| 0.2 |
2.8 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.2 |
0.6 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.2 |
0.4 |
GO:0090296 |
regulation of mitochondrial DNA replication(GO:0090296) |
| 0.2 |
0.2 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
1.1 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.2 |
0.6 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.2 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
1.7 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.2 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 |
5.2 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 |
2.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
0.4 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.2 |
1.0 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
1.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
0.4 |
GO:1900133 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) cell communication by chemical coupling(GO:0010643) regulation of renin secretion into blood stream(GO:1900133) |
| 0.2 |
0.4 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
4.3 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 |
2.0 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.2 |
1.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.8 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.2 |
0.4 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.2 |
1.0 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
2.6 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
2.0 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.2 |
0.8 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.2 |
0.6 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.2 |
0.8 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.2 |
1.6 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
0.6 |
GO:0002739 |
regulation of cytokine secretion involved in immune response(GO:0002739) |
| 0.2 |
0.2 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.2 |
1.0 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
0.4 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.2 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.2 |
0.2 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.2 |
1.2 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.2 |
2.1 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.2 |
1.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 |
0.9 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.2 |
0.2 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
4.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.2 |
0.4 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.2 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
0.2 |
GO:2000142 |
regulation of DNA-templated transcription, initiation(GO:2000142) |
| 0.2 |
3.5 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.2 |
0.4 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.2 |
3.5 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.2 |
0.9 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
2.0 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 |
1.5 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.2 |
0.9 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) |
| 0.2 |
1.8 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.2 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
6.0 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.2 |
0.9 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.2 |
0.9 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.2 |
0.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
0.5 |
GO:0090269 |
fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.2 |
0.2 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 |
1.1 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.2 |
0.7 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.2 |
1.2 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
0.4 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.2 |
1.4 |
GO:0032816 |
positive regulation of natural killer cell activation(GO:0032816) |
| 0.2 |
2.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
0.5 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
0.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.2 |
0.5 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 |
0.3 |
GO:0002260 |
lymphocyte homeostasis(GO:0002260) |
| 0.2 |
0.9 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.2 |
0.9 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.5 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
1.7 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.2 |
0.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.2 |
0.3 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 |
0.5 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.2 |
1.4 |
GO:0017004 |
cytochrome complex assembly(GO:0017004) |
| 0.2 |
0.7 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
0.8 |
GO:0009303 |
rRNA transcription(GO:0009303) ncRNA transcription(GO:0098781) |
| 0.2 |
2.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
0.3 |
GO:0045713 |
low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.2 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.2 |
0.3 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.2 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.2 |
0.5 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.2 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.3 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.2 |
2.0 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
| 0.2 |
3.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
0.6 |
GO:0031047 |
gene silencing by RNA(GO:0031047) |
| 0.2 |
1.0 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.2 |
3.2 |
GO:0043631 |
RNA polyadenylation(GO:0043631) |
| 0.2 |
0.5 |
GO:0003340 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.2 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
0.2 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.9 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
0.3 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.2 |
0.6 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.2 |
0.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.2 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 |
0.6 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.6 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
0.6 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
0.3 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.3 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 |
0.5 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.2 |
6.0 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.2 |
1.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.8 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.2 |
0.6 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
3.8 |
GO:0000077 |
DNA damage checkpoint(GO:0000077) DNA integrity checkpoint(GO:0031570) |
| 0.2 |
2.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 |
0.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
0.3 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
2.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.7 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.1 |
0.4 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.1 |
0.9 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 |
2.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.1 |
1.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.3 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.7 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.4 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.6 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.1 |
0.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.7 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 |
0.1 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.1 |
2.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
1.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.7 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
2.2 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.1 |
0.6 |
GO:0046545 |
development of primary female sexual characteristics(GO:0046545) |
| 0.1 |
0.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
1.8 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
4.0 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
1.1 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.3 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 |
1.1 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
0.3 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.1 |
0.4 |
GO:0051000 |
positive regulation of nitric-oxide synthase activity(GO:0051000) |
| 0.1 |
0.3 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.1 |
0.5 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.3 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.7 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.1 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
0.4 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.1 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.5 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.9 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 |
0.3 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) positive regulation of isotype switching(GO:0045830) |
| 0.1 |
0.4 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.0 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.9 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
2.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
3.1 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
2.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.7 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
0.5 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
1.8 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
0.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) cellular response to vitamin D(GO:0071305) |
| 0.1 |
0.3 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
0.5 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
0.2 |
GO:1990090 |
response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.1 |
1.6 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.1 |
4.1 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.1 |
0.1 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.1 |
0.1 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.1 |
0.9 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.5 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.6 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.1 |
1.0 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.4 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.1 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.5 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
1.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.2 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 |
1.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
1.4 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.3 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
1.2 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.5 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.5 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
0.8 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
1.0 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.5 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.1 |
GO:0070162 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
| 0.1 |
2.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
9.2 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.1 |
0.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.3 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
1.6 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.4 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.7 |
GO:0033523 |
histone H2B ubiquitination(GO:0033523) |
| 0.1 |
1.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.4 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.1 |
1.4 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.1 |
0.1 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.1 |
0.9 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.1 |
0.5 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0046605 |
regulation of centrosome cycle(GO:0046605) |
| 0.1 |
0.9 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
2.5 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.1 |
0.4 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.2 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.8 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.4 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.1 |
0.3 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.8 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.4 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
| 0.1 |
0.3 |
GO:0042832 |
response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
| 0.1 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.3 |
GO:0080111 |
DNA dealkylation(GO:0035510) DNA demethylation(GO:0080111) |
| 0.1 |
0.3 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.1 |
0.5 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
13.0 |
GO:0044772 |
mitotic cell cycle phase transition(GO:0044772) |
| 0.1 |
0.1 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 |
1.3 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.1 |
0.7 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 |
0.5 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.3 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 |
0.4 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.4 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.4 |
GO:1901031 |
regulation of response to reactive oxygen species(GO:1901031) |
| 0.1 |
0.2 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.4 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
0.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.3 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.4 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.4 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
1.0 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 |
0.3 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.1 |
0.1 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.2 |
GO:0072079 |
nephron tubule formation(GO:0072079) |
| 0.1 |
0.1 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.1 |
2.4 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
0.5 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.5 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
0.1 |
GO:0043537 |
negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.1 |
0.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.1 |
0.3 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 |
1.9 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.4 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.1 |
0.1 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.1 |
0.3 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
0.2 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.1 |
1.7 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 |
0.6 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.4 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.2 |
GO:0034115 |
negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
| 0.1 |
0.3 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) protein kinase D signaling(GO:0089700) |
| 0.1 |
0.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.2 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.1 |
0.3 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
1.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.2 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.8 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.6 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.7 |
GO:0031398 |
positive regulation of protein ubiquitination(GO:0031398) |
| 0.1 |
1.0 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.6 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.1 |
0.1 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.2 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.3 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.7 |
GO:0071897 |
DNA biosynthetic process(GO:0071897) |
| 0.1 |
0.3 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.1 |
1.2 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 |
1.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
1.3 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.1 |
0.3 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.6 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.1 |
1.6 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.1 |
0.1 |
GO:0009595 |
detection of biotic stimulus(GO:0009595) detection of external biotic stimulus(GO:0098581) |
| 0.1 |
0.4 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.1 |
2.5 |
GO:0008584 |
male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 |
1.0 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.2 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.4 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.1 |
1.1 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.1 |
0.6 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.1 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.1 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.5 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.3 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.1 |
0.3 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.1 |
3.8 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.3 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 |
0.4 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
0.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.3 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.3 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.1 |
0.2 |
GO:0060948 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) cardiac vascular smooth muscle cell development(GO:0060948) |
| 0.1 |
0.1 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
2.3 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.1 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.2 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.1 |
0.6 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.1 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 0.1 |
0.2 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.1 |
0.6 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.2 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.5 |
GO:0097150 |
neuronal stem cell population maintenance(GO:0097150) |
| 0.1 |
0.5 |
GO:0009948 |
anterior/posterior axis specification(GO:0009948) |
| 0.1 |
0.1 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
0.1 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.1 |
1.3 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.3 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
1.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.1 |
0.5 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.5 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.3 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.1 |
0.2 |
GO:2000177 |
regulation of neural precursor cell proliferation(GO:2000177) |
| 0.1 |
0.4 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.1 |
0.1 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.1 |
0.4 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.1 |
0.1 |
GO:0002583 |
regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.1 |
1.0 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 |
0.2 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.5 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.2 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
2.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
1.2 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.7 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.1 |
0.7 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.2 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
0.3 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.1 |
1.3 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.2 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.1 |
1.0 |
GO:0009855 |
determination of bilateral symmetry(GO:0009855) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
11.5 |
GO:0006412 |
translation(GO:0006412) |
| 0.1 |
0.1 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
6.5 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.1 |
1.3 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.2 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.2 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.1 |
0.2 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
6.4 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.5 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.4 |
GO:0042516 |
regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
| 0.1 |
0.1 |
GO:0060993 |
kidney morphogenesis(GO:0060993) |
| 0.1 |
0.1 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.1 |
1.0 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.2 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
1.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.0 |
0.0 |
GO:0033092 |
positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.0 |
0.7 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.2 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.2 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.6 |
GO:0061647 |
histone H3-K9 modification(GO:0061647) |
| 0.0 |
0.3 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.5 |
GO:0060563 |
neuroepithelial cell differentiation(GO:0060563) |
| 0.0 |
0.0 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.2 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.0 |
0.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.6 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.9 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.0 |
0.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.0 |
0.1 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.0 |
0.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 |
1.1 |
GO:1901184 |
regulation of ERBB signaling pathway(GO:1901184) |
| 0.0 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.2 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.1 |
GO:0070723 |
response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
| 0.0 |
0.2 |
GO:1900744 |
p38MAPK cascade(GO:0038066) regulation of p38MAPK cascade(GO:1900744) |
| 0.0 |
0.2 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.7 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.2 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.5 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.9 |
GO:0006633 |
fatty acid biosynthetic process(GO:0006633) |
| 0.0 |
0.1 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
| 0.0 |
1.1 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.1 |
GO:0071493 |
response to UV-B(GO:0010224) cellular response to UV-B(GO:0071493) |
| 0.0 |
0.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.3 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.3 |
GO:0042772 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.0 |
1.2 |
GO:0007519 |
skeletal muscle tissue development(GO:0007519) |
| 0.0 |
0.8 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 |
0.3 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.0 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.0 |
0.3 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.3 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.0 |
0.4 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.3 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
| 0.0 |
0.2 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.1 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.0 |
0.3 |
GO:0006360 |
transcription from RNA polymerase I promoter(GO:0006360) |
| 0.0 |
0.1 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.0 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.2 |
GO:0001824 |
blastocyst development(GO:0001824) |
| 0.0 |
0.0 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.2 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.0 |
0.5 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 |
0.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.1 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.0 |
0.7 |
GO:0090132 |
tissue migration(GO:0090130) epithelium migration(GO:0090132) |
| 0.0 |
0.2 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.2 |
GO:0061470 |
interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.3 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
0.1 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.1 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 |
0.5 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.2 |
GO:0072576 |
liver morphogenesis(GO:0072576) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.7 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.1 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.9 |
GO:0005976 |
polysaccharide metabolic process(GO:0005976) |
| 0.0 |
0.3 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.2 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.0 |
0.1 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.0 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.0 |
0.2 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.2 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.0 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.0 |
0.7 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.8 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.6 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.0 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.4 |
GO:0045930 |
negative regulation of mitotic cell cycle(GO:0045930) |
| 0.0 |
0.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.5 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 |
0.1 |
GO:0019395 |
fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
| 0.0 |
0.7 |
GO:1902593 |
protein import into nucleus(GO:0006606) protein targeting to nucleus(GO:0044744) single-organism nuclear import(GO:1902593) |
| 0.0 |
0.1 |
GO:0051193 |
regulation of cofactor metabolic process(GO:0051193) |
| 0.0 |
0.1 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.2 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.0 |
0.3 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.3 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.0 |
0.1 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.0 |
0.1 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.0 |
0.0 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.0 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.1 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.0 |
0.0 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.0 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.0 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
